James “Jim” Sigg FDA\'s Deputy Commissioner for Operations and Chief Operating Officer | Official Website
James “Jim” Sigg FDA\'s Deputy Commissioner for Operations and Chief Operating Officer | Official Website
This is unchanged from the number of companies cited in the previous quarter.
Of the 24 citations issued, the most common citation was 'You did not develop an FSVP'.
Most of the companies cited were involved in the Food and Cosmetics sector. The second most common type of company cited in the time period worked in the .
All of the companies cited should take voluntary actions to correct their managing operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Issue Cited |
---|---|---|---|
A Life Wholesale | Food and Cosmetics | 10/10/2023 | Develop FSVP |
Crown Fish, LLC | Food and Cosmetics | 10/24/2023 | Critical limits |
Crown Fish, LLC | Food and Cosmetics | 10/24/2023 | Monitoring - adequacy |
Crown Fish, LLC | Food and Cosmetics | 10/24/2023 | Corrective action plan |
Crown Fish, LLC | Food and Cosmetics | 10/24/2023 | Sanitation monitoring |
Eye Bank For Sight Restoration, Inc. | Biologics | 11/13/2023 | Adequate control, proper conditions |
Eye Bank For Sight Restoration, Inc. | Biologics | 11/13/2023 | Use prior to verification |
Eye Bank For Sight Restoration, Inc. | Biologics | 11/13/2023 | Accurate, indelible, legible |
Eye Bank For Sight Restoration, Inc. | Biologics | 11/13/2023 | Records incomplete |
Eye Bank For Sight Restoration, Inc. | Biologics | 11/13/2023 | Records maintained concurrently |
Kyewaa, LLC | Food and Cosmetics | 12/19/2023 | Develop FSVP |
New York Presbyterian Hospital-Columbia University Med. Center | Biologics | 11/28/2023 | Equipment observed, standardized, calibrated |
New York Presbyterian Hospital-Columbia University Med. Center | Biologics | 11/28/2023 | Establish, maintain and follow manufacturing SOPs |
New York Presbyterian Hospital-Columbia University Med. Center | Biologics | 11/28/2023 | Concurrent documentation |
New York Presbyterian Hospital-Columbia University Med. Center | Biologics | 11/28/2023 | Required records |
Pinnacle Fertility Labs New York | Biologics | 12/14/2023 | Testing, screening, donor eligibility procedures |
Ports America, Inc. | Food and Cosmetics | 10/10/2023 | Prevention of contamination |
Ports America, Inc. | Food and Cosmetics | 10/10/2023 | Signs for non-potable water |
TMRW Life Sciences, Inc. | Devices | 10/24/2023 | DHR - not or inadequately maintained |
Wild Edibles, Inc. | Food and Cosmetics | 12/07/2023 | HACCP plan implementation |
Wild Edibles, Inc. | Food and Cosmetics | 12/07/2023 | Sanitation monitoring |
Xtreem Pulse, LLC | Devices | 10/13/2023 | Design changes - Lack of or Inadequate Procedures |
Xtreem Pulse, LLC | Devices | 10/13/2023 | Design history file |
Xtreem Pulse, LLC | Devices | 10/13/2023 | Lack of or inadequate receiving acceptance procedures |